...
首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >Oral Administration of Forskolin, Homotaurine, Carnosine, and Folic Acid in Patients with Primary Open Angle Glaucoma: Changes in Intraocular Pressure, Pattern Electroretinogram Amplitude, and Foveal Sensitivity
【24h】

Oral Administration of Forskolin, Homotaurine, Carnosine, and Folic Acid in Patients with Primary Open Angle Glaucoma: Changes in Intraocular Pressure, Pattern Electroretinogram Amplitude, and Foveal Sensitivity

机译:原发性开角型青光眼患者口服佛司可林,高牛磺酸,肌氨酸和叶酸:眼内压,模式视网膜电图振幅和中央凹敏感性的变化

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate the effects of a food supplement containing forskolin, homotaurine, carnosine, folic acid, vitamins B1, B2, B6, and magnesium in patients with primary open angle glaucoma (POAG) already in treatment and compensated by intraocular pressure (IOP)-lowering drugs, during a period of 12 months. Methods: Twenty-two patients (44 eyes) with POAG, with their IOP compensated by topical drugs, were enrolled and randomly assigned to the food supplement or control treatment group. The additional food supplement treatment consisted of 2 tablets per day (1 in the morning, 1 in the evening) given for 1 year of a balanced association of homotaurine, Coleus forskohlii root extract, l-carnosine, folic acid, vitamins B1, B2, B6, and magnesium. Pattern Electroretinogram (PERG) amplitude, foveal sensitivity obtained with the visual field analyzer frequency doubling technology, and IOP were detected at enrollment (T0), 3 months (T1), 6 months (T2), 9 months (T3), and 12 months (T4). Results: We observed in treated patients a significant further decrease of IOP and an improvement of PERG amplitude at 6, 9, and 12 months, and foveal sensitivity at 12 months. All values remained substantially stable in control patients. Conclusions: The results of the present pilot study indicate that the components of the food supplement reach the eye in a detectable manner, as evidenced by the effects on the IOP. Moreover, they suggest a short-term neuroactive effect, as indicated by the improvement of PERG amplitude and foveal sensitivity in treated, but not in control patients.
机译:目的:评估含有福司可林,高牛磺酸,肌肽,叶酸,维生素B1,B2,B6和镁的食品补充剂对已经接受治疗并经眼压(IOP)补偿的原发性开角型青光眼(POAG)患者的疗效-在12个月内放下药物。方法:纳入22例(44只眼)POAG患者,其IOP由局部药物补偿,并随机分配至食品补充剂或对照组。额外的食品补充剂治疗包括每天2片(早晨1片,晚上1片),给予1年高牛磺酸,七叶锦葵根提取物,左旋肌氨酸,叶酸,维生素B1,B2, B6和镁。在入组(T0),3个月(T1),6个月(T2),9个月(T3)和12个月时检测到模式视网膜电图(PERG)幅度,通过视野分析仪倍频技术获得的中央凹敏感性和IOP (T4)。结果:我们观察到治疗的患者在6、9和12个月时IOP进一步明显降低,PERG幅度改善,而在12个月时中心凹敏感性增加。对照患者的所有值基本保持稳定。结论:目前的初步研究结果表明,食品添加剂的成分以可检测的方式到达眼睛,这对IOP产生了影响。而且,他们提示了短期的神经活性作用,这可以通过治疗的PERG振幅和中央凹敏感性的改善来表明,而对照组则没有。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号